Clinical evaluation of vaccines for pandemic influenza H5N1.
Avian influenza (H5N1) was first associated with human respiratory disease in Hong Kong in 1997. In 2004 the virus re-emerged among poultry and migratory birds in Asia and has spread into Europe and Africa, raising concerns that an H5 pandemic is imminent.
Pareek
Manish
M
Infectious Diseases Unit, University Hospitals Leicester, Leicester LE1 5WW.
Stephenson
Iain
I
D000349:Africa / Q000453:epidemiology; D004196:Disease Outbreaks / Q000331:legislation & jurisprudence / Q000517:prevention & control; D005060:Europe / Q000453:epidemiology; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000592:standards*; D007251:Influenza, Human / Q000517:prevention & control*; D014611:Vaccination / Q000331:legislation & jurisprudence
D007252:Influenza Vaccines